The effect on pulmonary fluid balance of adrenergic receptor agonist agents commonly employed in clinical sepsis has not been well characterized. Therefore, we tested the hypothesis that dobutamine would increase pulmonary microvasular fluid flux in experimental sepsis-induced lung injury. To define the effects of this synthetic catecholamine on pulmonary lymph flow (4L), we infused dobutamine in sheep at two doses in sequence (5pLg/kg/min and IOLg/kg/min) before and after the induction of intraperitoneal sepsis which resulted in the development of lung microvascular injury. In the nonseptic state, cardiac output increased at both 5p.g/kg/min and 10plg/kgImin (22 and 36 percent, respectively), while QL was unchanged from baseline (for 5p.g, AQL = + 0.44 ± 1.35 ml/15 min; not significant) (for 10plg, AQL = -0. 20 + 1.0 ml/15 min; not significant).
The effect on pulmonary fluid balance of adrenergic receptor agonist agents commonly employed in clinical sepsis has not been well characterized. Therefore, we tested the hypothesis that dobutamine would increase pulmonary microvasular fluid flux in experimental sepsis-induced lung injury. To define the effects of this synthetic catecholamine on pulmonary lymph flow (4L), we infused dobutamine in sheep at two doses in sequence (5pLg/kg/min and IOLg/kg/min) before and after the induction of intraperitoneal sepsis which resulted in the development of lung microvascular injury. In the nonseptic state, cardiac output increased at both 5p.g/kg/min and 10plg/kgImin (22 and 36 percent, respectively), while QL was unchanged from baseline (for 5p.g, AQL = + 0.44 ± 1.35 ml/15 min; not significant) (for 10plg, AQL = -0. 20 + 1.0 ml/15 min; not significant).
The development of noncardiac pulmonary edema (NCPE) is the consequence of an increase in permeability of the lung's microvascular exchanging membrane. The result is in an abnormal accumulation of extravascular lung water (EVLW) at normal microvascular hydrostatic pressures (Pmv).' Experimental findings have also documented that an increase in either the Pmv2 or the surface area of the lung's microvascular exchanging membrane3 secondarily promotes accumulation of extravascular lung water in noncardiac pulmonary edema.
Patients with the adult respiratory distress syndrome (ARDS) frequently require pharmacologic support to maintain adequate peripheral oxygen availability. 4 Beta-adrenergic receptor agonists may thereby be employed to augment cardiac output (hence systemic oxygen transport), even when systemic pressures are considered to be ranges;5'6 however, theoretically, such agents might depress systemic oxygen transport if, among other reasons, a reduction in arterial oxygen saturation resulted from enhanced edema formation or a loss of hypoxic vasoconstriction. In ARDS, ,3-adrenergic receptor agonists might worsen pulmonary microvascular fluid flux, thereby further augmenting edema formation and depressing arterial oxygen content, by increasing the surface area across which fluid exchange occurs within the lung, by primarily altering the lung's endothelial permeablity characteristics, or by effecting an increase in the Pmv.
In healthy animals, Minnear et a17 demonstrated that an infusion of norepinephrine was associated with an increase in pulmonary lymph flow (QL) and a concurrent decrease in the ratio of lymph-to-plasma total protein levels ([L/P]TP); these data implied that an increase in pulmonary microvascular fluid flux during infusion of norepinephrine was due to an increase in the Pmv. Sibbald) secondary to an infusion of endotoxin. Uncertainty therefore remains as to the effects of exogenously administered catecholamines on microvascular fluid flux in healthy animals; there may be even less appreciation of the effect of such agents on pulmonary microvascular fluid flux when administered during a period of established lung injury. Dobutamine is a synthetic f-adrenergic receptor agonist which is frequently used in clinical sepsis, the latter an important cause of noncardiac pulmonary edema.'0 Since it has been suggested that dobutamine may be a preferred adrenergic receptor agonist to augment systemic flows in acute hypoxemic respiratory failure,5 we examined its effects on pulmonary microvascular fluid flux in sheep in a model of intraperitoneal sepsis which is complicated by lung injury. " 
MATERIALS AND METHODS

Experimental Preparation
Ten mature Suffolk sheep, weighing 30 to 40 kg (0.9 to 1.2 m2 of body surface area), were prepared with chronic lymph fistulae using a modification of the technique described by Staub et al.' Before study the sheep were premedicated with atropine sulfate and were then anesthetized and intubated. We cannulated the aorta with a nonheparinized Silastic catheter (medical grade tubing; 0.125 outer diameter; Dow Corning) and the pulmonary artery with a No. 8 French, right-heart flow-directed thermodilution catheter (Edwards model 93A-131). " The right-heart catheter position was confirmed by the presence of typical pressure recordings. With the balloon inflated, a pulmonary arterial wedge tracing was documented. The balloon was then deflated, and the catheter was flushed for the duration of the experiment with a continuous infusion of 5 percent dextrose in water, to which 1,000 units of heparin had been added (1.0 ml/hr).
Using a right posterolateral thoracotomy through the sixth interspace, the efferent duct ofthe caudal mediastinal lymph node was then cannulated with a nonheparinized Silastic catheter (medical grade tubing with 0.025 inner diameter and 0.047 outer diameter; Dow Corning). The catheter was secured and externalized through the chest wall. The tail of the caudal mediastinal lymph node was identified, ligated, and divided below the level of the inferior pulmonary ligament. To further reduce potential for contamination by nonpulmonary lymph,13 all identifiable diaphragmatic and chest wall afferent lymphatic vessels were cauterized in a manner similar to that described by others. ' (25 mg) intravenously to minimize the pain of the thoracotomies and a subsequent laparotomy.
Experimental Protocol
Baseline studies were performed over a 120-minute period approximately three to four days after recovery from preliminary surgery. Pulmonary lymph was collected and measured for volume every 15 minutes; lymph was pooled at the end of the two-hour baseline period for measurement oftotal protein and albumin. At the midpoint of this baseline "nonseptic" study, we measured systemic and pulmonary arterial pressures, as well as cardiac output. Blood was drawn from the arterial line and distal port of the right-heart catheter for chemical analysis, hematologic studies, and measurement of arterial and central venous blood gas levels. Dobutamine (500 mg dissolved in 500 ml of 5 percent dextrose in water) was then sequentially administered at two doses (5p.g/kg/min and 10lg/kg/ min) for a 60-minute infusion period with each. The first 15 to 30 minutes of infusion at each dose represented a period of equilibration. Pulmonary lymph was collected and measured for volume during each of the last two 15-minute periods of infusion; it was subsequently pooled for measurement of total protein and albumin. Blood was drawn for hematologic studies, chemical analysis, and blood gas levels at the end ofeach ofthe last two 15-minute periods of infusion. We also repeated measurement of the cardiac output, and systemic and pulmonary arterial pressures at the same time. Therefore, values reported during infusion of the drug at both doses represent the average of two measurements obtained during two timed 15-minute periods of collection.
Following the nonseptic study, an intra-abdominal source ofsepsis was created in the sheep, as previously described. " Under general anesthesia with halothane, a lower midline laparotomy was performed; the cecum and ileocecal valve were then identified, and approximately 6 to 8 cm of the distal cecum was devascularized. The bulk of fecal material was milked back into the proximal cecum and right colon. The distal cecum was circumferentially ligated with a No. 2 silk tie below the level of the ileocecal valve. After making a 2-cm perforation in the cecal tip, the compromised bowel was returned to the right lower quadrant. The gastrocolic omentum was then ligated and divided to prevent any early localization of the subsequent inflammatory process. The abdomen was closed in layers, and all animals were returned to their cages and allowed free access to food and water.
"Sepsis syndrome," complicated by pulmonary microvascular injury, was defined as an increase in cardiac output and QL, the latter to levels at least 30 percent above preseptic measurements;"1 this usually occurred between 24 and 48 hours after establishing intraabdominal contamination. At this time, baseline septic measurements were performed, as previously described for the nonseptic study. Dobutamine was then infused for 60 minutes at each of the two doses defined; all measurements previously detailed were repeated and averaged during the last two 15-minute periods of infusion at both the 5>Lg/kg/min and IOLg/kg/min doses.
Specific Measurements
We collected pulmonary lymph in graduated heparinized tubes. From pooled lymph specimens, we measured total protein and albumin concentrations (in grams per deciliter) by the Biuret method"5 using an automated system (Auto Analyzer, Technicon Instruments); duplicate samples differed by less than 5 percent.
At the time of lymph collection, we also measured total protein and albumin concentration (in grams per deciliter). With appropriate temperature corrections, we measured oxygen tension (Po,, in millimeters of mercury) (AME-1 blood gas analyzer) and oxygen saturation (So,, in percent) (Hemoximeter, Radiometer) of both arterial (eg, PaO,) and mixed venous (eg, PiVO,) blood drawn from the carotid arterial line and the distal lumen of the right-heart catheter, respectively. Blood for determining gas levels was drawn into heparinized syringes and maintained in ice until determination was performed within 15 minutes of collection.
We measured systolic, diastolic, and mean values for systemic blood pressure and for pulmonary arterial pressure and measured left atrial (LAP) and pulmonary arterial wedge pressures (PCWP) with an arterial/venous pressure transducer (Hewlett-Packard) and a digital display with a continuous paper recording system (HewlettPackard arterial/venous pressure module 78205B). Transducers were leveled to the humeral tuberosity, taken as the level of the right atrium in sheep. The portable computer (Edwards model 9520), using 10 ml of iced saline solution (00 C). We calculated the colloid osmotic pressure in both serum (irmv) and lymph (7rpmv) and corrected for the albumin/globulin ratio."6 The pulmonary vascular resistance index (PVRI), stroke volume index (SVI), systemic oxygen consumption (Vo2) and oxygen transport, (02+) indexed for body surface area (BSA), were calculated from measured hemodynamic parameters. Body surface area for sheep was caculated by the following formula: BSA= (weight in kg x 
Statistics
Data are expressed as the mean ± standard deviation. Statistical comparisons were made using Student's paired or unpaired t-test, as indicated, and a p value of less than 0.05 was considered significant. Regression analyses were also used with independent variables to describe and predict a dependent variable as a function of these variables.
nary arterial pressure at either dose (Table 1 and Fig 1) . The cardiac output increased progressively with both doses, while the measured pulmonary arterial wedge pressure, left atrial pressure, and calculated Pmv remained unchanged. Systemic oxygen transport increased at both doses, and the PMO2 increased concurrently.
Dobutamine did not signficantly affect QL or the [L/P]TP at either dose. The calculated mean rpmv fell with both doses (p<0.05), although the -rrmv-'rpmv gradient was unchanged from baseline. Therefore, the CLP remained unchanged from baseline during the infusion of dobutamine of either dose.
We found no significant relationship between changes in QL and cardiac output (CO) at either dose (5p1g/kg/min, AQL= 2; Fig 1) . Similarly, when compared to the baseline nonseptic study, QL had increased, while the values for [L/P]TP ratios were unchanged; CLP, therefore, was also increased above baseline nonseptic study. Both the rrmv and 'Tpmv had declined by the baseline septic study, although the lTmv-lrpmv gradient remained unchanged (Table 2) . Again, we found no correlation between the cardiac output and Q Lat baseline, when combining both septic and nonseptic studies (r = 0.22; p not significant). We have previously interpreted the finding of an increase in QL without a significant fall in [L/P]TP ratios, as indicative of a permeability lesion within the pulmonary microvasculature of sheep with an intraperitoneal focus of sepsis."l During the septic study, the infusion of dobutamine was associated with a progressive decline in the mean systemic blood pressure throughout the two dosing regimens employed (Table 2) ; however, it was without effect on the mean pulmonary arterial pressure. Since the cardiac output increased with both doses, the calculated PVRI, therefore, fell. Systemic oxygen transport increased at both doses, although the PaO, and systemic Vo2 remained unchanged. The calculated Pmv did not change, while the pulmonary arterial wedge pressure increased significantly above baseline at only the 5Rg/kg/min dose (+ 22 percent) and the left atrial pressure remained unchanged from baseline at both doses.
A significant increase in QL was noted with low-dose infusion (+ 24 percent) but not at the higher dose; [L/P]TP ratios also fell at the low dose but not at the higher dose. Therefore, CLP increased significantly from the baseline septic study only with the 5[ag/kg/ min dose and not with the lOig/kg/min dose. Except for the highest dose employed (10.g/kg/min, y = 0.37 + 0. 91x; r = 0. 67), no significant relationship was found between changes in Q and changes in the cardiac ouput (CO) (5 pLg/kg/min, AOL =1.31+0.13 CO; r=0.014).
DiscusSION
The flow-dependency of systemic .Vo,, which is frequently demonstrable when ARDS complicates the "sepsis syndrome,"6'20 may clinically dictate the use of the lung's exchanging microvasculature. Studies from which the effects of 3-adrenergic receptor agonists on lung microvascular fluid flux might be related to the clinical correlate have either been performed in healthy animals7,8 or were designed as a pretreatment protocol;9 conclusions therein derived may well not characterize the effects of exogenous catecholamines on both lung microvascular fluid flux and systemic hemodynamics in the "sepsis syndrome" is also critically important; for example, endotoxin models of on both lung microvascular fluid flux and systemic hemodynamics in the "sepsis syndrome" is also critically important; for example, endotoxin models of lung microvascular injury may only reflect a later period in a progression of the "sepsis syndrome" because of the marked dissimilarities noted in both flow and pressure characteristics (among others) between this model23'24 and early human sepsis.4'6 Therefore, when administered to an endotoxic model,9'23 conclusions about the effects of P3-adrenergic receptor agonists on lung fluid balance may also not represent their real effects during the early phases of ARDS complicating human sepsis.
Since dobutamine has been recommended as an adrenergic receptor agonist which might be used in preference to dopamine when systemic flows require pharmacologic support in ARDS,' we studied its effects on fluid flux in an animal model of peritonitis which is characterized by lung microvascular injury. This model seems more representative of early clinical sepsis than are endotoxic models, since it is characterized by a high systemic flow and low peripheral resistance state, with maintenance of systemic pressures. 1 2 ' We evaluated the effects of dobutamine on microvascular fluid exchange in the lung of chronically cannulated sheep by using changes in the magnitude of QL to reflect changes in water flux and using changes in the CLP to represent changes in protein flux.
The remote effects of surgically induced peritonitis on the lung's microvascular exchanging membrane were seen as an increase in QL, without a significant depression in [L/P]TP ratios. Hence, CLP, or protein flux, was also increased with the onset of "sepsis syndrome." Concurrently, both the cardiac output and the mean pulmonary artery pressure were greater than was observed in the nonseptic studies. An increase in QL, with unchanged [L/P]TP ratios, must represent the effects of an increase in either endothelial permeability or in the surface area ofthe lung's exchanging membrane on lung microvascular fluid flux. Although an increase in QL secondary to intraperitoneal contamination may arguably have been the consequence of an increase in the lung's perfused surface area, previous morphologic examination of this model has documented that a permeability lesion is the primary explanation for an observed increase in QL with the onset of sepsis. were not likely to be responsible for the slight increase noted in QL19 Therefore, the data are most consistent with an interpretation that a "hydrostatic" effect was primarily responsible for the changes documented in pulmonary QL with low-dose dobutamine infusion. Since the pulmonary arterial wedge pressure was significantly elevated from baseline at this dose, without any concurrent change in the left atrial pressure, it is conceivable that a pressure gradient was established between the left atrium and the lung's microvascular exchanging membrane, and that such was thereby responsible for the modest increase in QL observed during low-dose dobutamine infusion.
Why we found no effect of dobutamine on QLat the lOfg/kg/min dose, nor on QL at either dose in the nonseptic study, is speculative. As suggested by O'Bradovich and Coates,'8 23-adrenergic receptor agonists might well not increase the surface area of the lung's exchanging membrane, as would be expected from a comparable increase in cardiac output when mediated by exercise;'9 however, in the septic study, such may not be a sufficient explanation, as changes in those factors responsible for pulmonary microvascular fluid flux should effect an exaggerated response in QL when the microvascular membrane is characterized by a permeability lesion.29 Thus, an increase in QL ofonly 24 percent during low-dose dobutamine infusion in the septic study is in contrast to an increase in QL of 296 percent when cardiac output was increased by 85 percent in exercising sheep where microemboli were Effect of Dobutamine on Lung Microvascular Fluid Flux in Sheep (Gnidec, Finley, Sibbald) used to concurrently induce a permeability defect.29 Therefore, it may be suggested that QL should have increased more than was observed with either dose of dobutamine infused during the septic study. It is possible that dobutamine minimized an anticipated increase in QL in both the preseptic and septic studies by primarily affecting those mechanisms which govern the transendothelial flux of fluid and protein at the level of the pulmonary microvascular membrane. A similar explanation was proposed by Walman et al9 when pretreatment with the P,-adrenergic agonist, isoproterenol, reduced edema formation following an infusion of endotoxin. To further support our suggestion that dobutamine may have functionally reduced the effects of altered endothelial permeability characteristics on microvascular fluid flux in this study, Hakim et al30 concluded that 3-adrenergic receptors regulated pulmonary transendothelial transport of fluid and proteins since 3-adrenergic blockade with propranolol was associated with an increase in QL. Also, in the peripheral microvasculature, 3-adrenergic receptor agonists demonstrably inhibit edema formation and transmicrovascular protein flux, an observation that cannot be explained by their effects on microvascular pressure, blood flow, or surface area.3' The rationale underlying such a protective action of P3-adrenergic receptor agonists within the pulmonary microvasculature is purely speculative but may reflect the effects of enhanced cyclic AMP generation within the endothelium, perhaps thereby leading to relaxation of mediator-contracted endothelial cells. 32 Alternatively, dobutamine may have reduced an anticipated increase in QL by affecting the intrinsic propulsive activity ofthe pulmonary lymphatic vessels; however, it is likely that were dobutamine to have influenced lymphatic contractility, we agonists in ARDS, due to their sometimes unique effect on both the pulmonary microvascular surface area and the Pmv;5 however, unlike clinical reports, dobutamine administration was not associated with a decline in the left atrial pressure. Nonetheless, its minim.al effects on pulmonary fluid balance, as systemic oxygen transport was augmented, support previous suggestions that this P3-adrenergic receptor agonist may be an ideal choice in acute hypoxemic respiratory failure secondary to ARDS when systemic flows and systemic oxygen transport need to be pharmacologically supported.
